US Patent Issued to MEDIPOST on May 20 for "Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory disease" (South Korean Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,534, issued on May 20, was assigned to MEDIPOST Co. LTD (Seongnam-si, South Korea).

"Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory disease" was invented by Yun Sun Yang (Seongnam-si, South Korea), Wonil Oh (Seongnam-si, South Korea), Soo Jin Choi (Seongnam-si, South Korea), Jihye Kwak (Seongnam-si, South Korea), Dong Hyon Kim (Seongnam-si, South Korea) and Hoon Lim (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition comprising HLA-A2-expressing mesenchymal stem cells as an effective ingredient and its use in prevention...